4 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 4 |
| Phase 2 | 1 | Unknown 1 |
Follow Chromosome Disorders: new trials by email Literature Review of Chromosome Disorders trials Research Report on Chromosome Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial Follow-up study of the treated cohort, Follow-up study of the untreated cohort - Prader-Willi Syndrome | Phase 3 | Unknown | University Hospital, Toulouse | 80 | 2021-09-07 | 2024-04-30 |
| A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome Recombinant Human Growth Hormone (rhGH) Injection - Prader-Willi Syndrome | Phase 3 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 30 | 2018-04-14 | 2018-06-12 |
| Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome. omega-3 PUFAs, Standard care, placebo - 22q11 Deletion Syndrome | Phase 2 / Phase 3 | Unknown | Bambino Gesù Hospital and Research Institute | 80 | 2014-06-01 | 2014-02-25 |
| Vitamin E in Aging Persons With Down Syndrome Vitamin E, multivitamin, Placebo - Down Syndrome, Alzheimer Disease | Phase 3 | Unknown | New York State Institute for Basic Research | 350 | 2002-04-01 | 2012-05-04 |
Prader-Willi Syndrome (2) · 22q11 Deletion Syndrome (1) · Alzheimer Disease (1) · Down Syndrome (1) · Psychotic Disorders (1)
Abnormalities, Multiple (4) · Congenital Abnormalities (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Genetic Diseases, Inborn (4) · Intellectual Disability (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Imprinting Disorders (2) · Mental Disorders (2) · Nutrition Disorders (2) · Nutritional and Metabolic Diseases (2) · Obesity (2) · Overnutrition (2)
Fish Oils (1) · Geritol (1) · Growth Hormone (1) · Standard of Care (1) · Tocopherols (1) · Vitamin E (1)
Bambino Gesù Hospital and Research Institute (1) · Changchun GeneScience Pharmaceutical Co., Ltd. (1) · New York State Institute for Basic Research (1) · University Hospital, Toulouse (1)
Australia (1) · Canada (1) · China (1) · France (1) · Holy See (1) · United Kingdom (1) · United States (1)
Arthur J Dalton, PhD (1) · Feihong Luo, Doctor (1) · Marco Armando, MD, PhD (1) · Mary C Sano, PhD (1) · Paul S Aisen, MD (1)
R01AG016381 (1)